CN Patent

CN120484066A — 棘白菌素类似物及其制备方法

Assigned to Fujian Shengdi Pharmaceutical Co ltd · Expires 2025-08-15 · 1y expired

What this patent protects

本公开涉及棘白菌素类似物及其制备方法，该类化合物可用于预防或者治疗真菌感染，或者用于预防、稳定或抑制真菌生长或杀死真菌，示例化合物如式I所示，其中R 1 、R 2 、R 3 及G基团的定义如说明书中所述。

USPTO Abstract

本公开涉及棘白菌素类似物及其制备方法，该类化合物可用于预防或者治疗真菌感染，或者用于预防、稳定或抑制真菌生长或杀死真菌，示例化合物如式I所示，其中R 1 、R 2 、R 3 及G基团的定义如说明书中所述。

Drugs covered by this patent

Patent Metadata

Patent number
CN120484066A
Jurisdiction
CN
Classification
—
Expires
2025-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Fujian Shengdi Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.